In the last trading session, 3.29 million shares of the Mainz Biomed N.V. (NASDAQ:MYNZ) were traded, and its beta was 0.09. Most recently the company’s share price was $0.26, and it changed around $0.0 or -1.16% from the last close, which brings the market valuation of the company to $5.60M. MYNZ currently trades at a discount to its 52-week high of $3.39, offering almost -1203.85% off that amount. The share price’s 52-week low was $0.19, which indicates that the current value has risen by an impressive 26.92% since then. We note from Mainz Biomed N.V.’s average daily trading volume that its 10-day average is 2.28 million shares, with the 3-month average coming to 2.03 million.
Mainz Biomed N.V. stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended MYNZ as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Mainz Biomed N.V. is expected to report earnings per share of -0.25 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Mainz Biomed N.V. (NASDAQ:MYNZ) trade information
Instantly MYNZ has showed a red trend with a performance of -1.16% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.3200 on recent trading dayincreased the stock’s daily price by 18.75%. The company’s shares are currently down -77.93% year-to-date, but still down -11.88% over the last five days. On the other hand, Mainz Biomed N.V. (NASDAQ:MYNZ) is 3.64% up in the 30-day period. We can see from the shorts that 1.7 million shares have been sold at a short interest cover period of 0.66 day(s).
Mainz Biomed N.V. (MYNZ) estimates and forecasts
Mainz Biomed N.V. share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -70.47 percent over the past six months and at a 45.68% annual growth rate that is well above the industry average of 17.50%. The year-over-year growth rate is expected to be 34.10%, up from the previous year.
Consensus estimates provided by 2 financial analysts predict the company will bring in an average of 220k in revenue for the current quarter. 2 analysts expect Mainz Biomed N.V. to make 300k in revenue for the current ending quarter. Analysts predict that the company’s current quarter sales will drop, forecast at -12.00%.
MYNZ Dividends
Mainz Biomed N.V.’s next quarterly earnings report is expected to be released in November.
VONTOBEL HOLDING LTD., with 0.1181% or 25000.0 shares worth $10025.0 as of 2024-06-30, holds the second largest percentage of outstanding shares.
